TrialClinical cancer research : an official journal of the American Association for Cancer Research2024

Pembrolizumab and Cabozantinib in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Long-term Survival Update with a Biomarker Analysis.

Nabil F Saba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.